Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods

被引:44
作者
Best, LM
Haldane, DJM
Keelan, M
Taylor, DE
Thomson, ABR
Loo, V
Fallone, CA
Lyn, P
Smaill, FM
Hunt, R
Gaudreau, C
Kennedy, J
Alfa, M
Pelletier, R
van Zanten, SJOV
机构
[1] Dalhousie Univ, Queen Elizabeth II Ctr Clin Res, Halifax, NS B3H 1V9, Canada
[2] Dalhousie Univ, Div Gastroenterol, Halifax, NS, Canada
[3] Univ Alberta, Edmonton, AB, Canada
[4] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[5] Hop St Luc, Montreal, PQ H2X 1P1, Canada
[6] Univ Quebec, Ctr Hosp, Quebec City, PQ, Canada
[7] McMaster Univ, Ctr Hlth, Hamilton, ON, Canada
[8] St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada
关键词
D O I
10.1128/AAC.47.10.3138-3144.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Susceptibility testing was performed at seven Canadian microbiology laboratories and the Helicobacter Reference Laboratory, Halifax, Nova Scotia, Canada, to assess susceptibility testing proficiency and the reproducibility of the results for clarithromycin and metronidazole and to compare the Epsilometer test (E test) method to the agar dilution reference method. Control strain Helicobacter pylori ATCC 43504 (American Type Culture Collection) and 13 clinical isolates (plus duplicates of four of these strains including ATCC 43504) were tested blindly. The National Committee for Clinical Laboratory Standards (NCCLS) guidelines for agar dilution testing were followed, and the same suspension of organisms was used for agar dilution and E test. Antimicrobials and E test strips were provided to the investigators. Methods were provided on a website (www.Helicobactercanada.org). Each center reported MICs within the stated range for strain ATCC 43504. Compared to the average MICs, interlaboratory agreements within 2 log(2) dilutions were 90% (range, 69 to 100%) for clarithromycin by agar dilution, with seven very major errors [VMEs], and 85% (range, 65 to 100%) by E test, with three VMEs. Interlaboratory agreements within 2 log, dilutions were 83% (range, 50 to 100%) for metronidazole by agar dilution, with six VMEs and eight major errors (MEs), and 75% (range, 50 to 94%) by E test, with four VMEs and four MEs. At lower and higher concentrations of antibiotic, E test MICs were slightly different from agar dilution MICs, but these differences did not result in errors. When a standardized protocol based on NCCLS guidelines was used, most participants in this study correctly identified clarithromycin- and metronidazole-susceptible and -resistant strains of H. pylori 93% of the time by either the agar dilution or E test method, and the numbers of errors were relatively equivalent by both methods.
引用
收藏
页码:3138 / 3144
页数:7
相关论文
共 49 条
[1]   Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia [J].
Al-Qurashi, AR ;
El-Morsy, F ;
Al-Quorain, AA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (03) :233-236
[2]   The HOMER study:: The effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection [J].
Bardhan, KD ;
Bayerdörffer, E ;
Van Zanten, SJOV ;
Lind, T ;
Mégraud, F ;
Delchier, JC ;
Hellblom, M ;
Stubberöd, A ;
Burman, CF ;
Gromark, PO ;
Zeijlon, L .
HELICOBACTER, 2000, 5 (04) :196-201
[3]  
Bazzoli F, 2001, EUR J GASTROEN HEPAT, V13, pS3
[4]   Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population [J].
Bernstein, CN ;
McKeown, I ;
Embil, JM ;
Blanchard, JF ;
Dawood, M ;
Kabani, A ;
Kliewer, E ;
Smart, G ;
Coghlan, G ;
MacDonald, S ;
Cook, C ;
Orr, P .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (04) :668-674
[5]   Helicobacter pylori: Primary susceptibility to clarithromycin in vitro in Nova Scotia [J].
Best, LM ;
Haldane, DJM ;
Bezanson, GS ;
vanZanten, SJOV .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 11 (04) :298-300
[6]   Assessment of metronidazole susceptibility in Helicobacter pylori: Statistical validation and error rate analysis of breakpoints determined by the disk diffusion test [J].
Chaves, S ;
Gadanho, M ;
Tenreiro, R ;
Cabrita, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1628-1631
[7]   Significance of anaerobic preincubation of Helicobacter pylori for measuring metronidazole susceptibility by the Etest [J].
Chida-Sakata, N ;
Baba, M ;
Inagawa, H ;
Wada, A ;
Tanaka, T ;
Hoshihara, Y ;
Takemoto, T .
MICROBIOLOGY AND IMMUNOLOGY, 1999, 43 (05) :397-401
[8]   Guidelines on the management of H-pylori in primary care:: development of an implementation strategy [J].
de Wit, NJ ;
Mendive, J ;
Seifert, B ;
Cardin, F ;
Rubin, G .
FAMILY PRACTICE, 2000, 17 :S27-S32
[9]   Does Helicobacter pylori eradication prevent gastric cancer? [J].
Fallone, CA ;
Barkun, AN ;
Halwani, F .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (09) :803-804
[10]  
Fallone CA, 1999, CLIN INVEST MED, V22, P185